199 related articles for article (PubMed ID: 25893008)
21. American Medical Society for Sports Medicine position statement: concussion in sport.
Harmon KG; Drezner JA; Gammons M; Guskiewicz KM; Halstead M; Herring SA; Kutcher JS; Pana A; Putukian M; Roberts WO
Br J Sports Med; 2013 Jan; 47(1):15-26. PubMed ID: 23243113
[TBL] [Abstract][Full Text] [Related]
22. Structural Neuroimaging Findings Related to Adult Non-CNS Cancer and Treatment: Review, Integration, and Implications for Treatment of Cognitive Dysfunction.
McDonald BC
Neurotherapeutics; 2021 Apr; 18(2):792-810. PubMed ID: 34402034
[TBL] [Abstract][Full Text] [Related]
23. Long-term Cognitive and Functional Impairments After Critical Illness.
Rengel KF; Hayhurst CJ; Pandharipande PP; Hughes CG
Anesth Analg; 2019 Apr; 128(4):772-780. PubMed ID: 30883422
[TBL] [Abstract][Full Text] [Related]
24. A randomized trial of cognitive rehabilitation in cancer survivors.
Cherrier MM; Anderson K; David D; Higano CS; Gray H; Church A; Willis SL
Life Sci; 2013 Oct; 93(17):617-22. PubMed ID: 24012579
[TBL] [Abstract][Full Text] [Related]
25. Cognitive Dysfunction: Feasibility of a Brief Intervention to Help Breast Cancer Survivors.
Radomski M; Kreiger R; Anheluk M; Berling K; Darger M; Garcia H; Grabe K; Hopkins S; Morrison M; Zola J; Swenson KK
Clin J Oncol Nurs; 2021 Dec; 25(6):E69-E76. PubMed ID: 34800105
[TBL] [Abstract][Full Text] [Related]
26. [Cognition, schizophrenia and the effect of antipsychotics].
Stip E
Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
[TBL] [Abstract][Full Text] [Related]
27. A Delphi technique toward the development of a cognitive intervention framework module for breast cancer survivors with cognitive impairment following chemotherapy.
Syed Alwi SM; Mazlan M; Mohd Taib NA; Che Din N; Narayanan V
PLoS One; 2022; 17(11):e0277056. PubMed ID: 36395277
[TBL] [Abstract][Full Text] [Related]
28. Protective Effects of
Van Dyk K; Zhou X; Small BJ; Ahn J; Zhai W; Ahles T; Graham D; Jacobsen PB; Jim H; McDonald BC; Nudelman Holohan K; Patel SK; Rebeck GW; Root JC; Saykin AJ; Cohen HJ; Mandelblatt JS; Carroll JE
JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 33748669
[TBL] [Abstract][Full Text] [Related]
29. Integrating cognitive rehabilitation: A preliminary program description and theoretical review of an interdisciplinary cognitive rehabilitation program.
Fleeman JA; Stavisky C; Carson S; Dukelow N; Maier S; Coles H; Wager J; Rice J; Essaff D; Scherer M
NeuroRehabilitation; 2015; 37(3):471-86. PubMed ID: 26518536
[TBL] [Abstract][Full Text] [Related]
30. "Is My Brain Ever Going to Work Fully Again?": Challenges and Needs of Cancer Survivors with Persistent Cancer-Related Cognitive Impairment.
Haywood D; Dauer E; Baughman FD; Lawrence BJ; Rossell SL; Hart NH; O'Connor M
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001592
[TBL] [Abstract][Full Text] [Related]
31. Impact of integrated yoga therapy on cognitive impairment and cardiac dysfunction in relation to quality of life in breast cancer patients undergoing chemotherapy: Study protocol for a two-arm randomized controlled trial.
Inbaraj G; Sathyaprabha TN; Udupa K; Ram A; Patil S; Rajeswaran J; Nandakumar KK; Belur S; Singh AD; Prathyusha PV; Bayari SK; Raghavendra RM
Front Oncol; 2022; 12():955184. PubMed ID: 36185291
[TBL] [Abstract][Full Text] [Related]
32. Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.
Dias-Carvalho A; Ferreira M; Ferreira R; Bastos ML; Sá SI; Capela JP; Carvalho F; Costa VM
Arch Toxicol; 2022 Jan; 96(1):11-78. PubMed ID: 34725718
[TBL] [Abstract][Full Text] [Related]
33. A Call for a Neuroscience Approach to Cancer-Related Cognitive Impairment.
Horowitz TS; Suls J; Treviño M
Trends Neurosci; 2018 Aug; 41(8):493-496. PubMed ID: 29907436
[TBL] [Abstract][Full Text] [Related]
34. Mild cognitive impairment and prospective memory: translating the evidence into neuropsychological practice.
Kinsella GJ; Pike KE; Cavuoto MG; Lee SD
Clin Neuropsychol; 2018 Jul; 32(5):960-980. PubMed ID: 29708011
[TBL] [Abstract][Full Text] [Related]
35. Similar neurocognitive patterns in patients treated with lenalidomide: chemobrain effect?
Calvi E; Marchetti M; Santagata F; Luppi C; Coppo E; Massaia M; Isaia GC
Neurocase; 2019 Dec; 25(6):259-262. PubMed ID: 31522586
[No Abstract] [Full Text] [Related]
36. Prediction of Cognitive Decline in Temporal Lobe Epilepsy and Mild Cognitive Impairment by EEG, MRI, and Neuropsychology.
Höller Y; Butz KHG; Thomschewski AC; Schmid EV; Hofer CD; Uhl A; Bathke AC; Staffen W; Nardone R; Schwimmbeck F; Leitinger M; Kuchukhidze G; Derner M; Fell J; Trinka E
Comput Intell Neurosci; 2020; 2020():8915961. PubMed ID: 32549888
[TBL] [Abstract][Full Text] [Related]
37. Cognitive dysfunction in post-COVID-19 condition: Mechanisms, management, and rehabilitation.
Möller M; Borg K; Janson C; Lerm M; Normark J; Niward K
J Intern Med; 2023 Nov; 294(5):563-581. PubMed ID: 37766515
[TBL] [Abstract][Full Text] [Related]
38. Genetic Variants Associated with Longitudinal Cognitive Performance in Older Breast Cancer Patients and Controls.
Nudelman K; Nho K; Zhang M; McDonald BC; Zhai W; Small BJ; Wegel CE; Jacobsen PB; Jim HSL; Patel SK; Graham DMA; Ahles TA; Root JC; Foroud T; Breen EC; Carroll JE; Mandelblatt JS; Saykin AJ
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296840
[No Abstract] [Full Text] [Related]
39. A randomised controlled trial evaluating two cognitive rehabilitation approaches for cancer survivors with perceived cognitive impairment.
Vardy JL; Pond GR; Bell ML; Renton C; Dixon A; Dhillon HM
J Cancer Surviv; 2023 Dec; 17(6):1583-1595. PubMed ID: 36241767
[TBL] [Abstract][Full Text] [Related]
40. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
Lange M; Joly F; Vardy J; Ahles T; Dubois M; Tron L; Winocur G; De Ruiter MB; Castel H
Ann Oncol; 2019 Dec; 30(12):1925-1940. PubMed ID: 31617564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
